Company Overview
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXTRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-6M
2025 FY
Shares Outstanding
—M
2025 FY
EPS
USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1335105
Exchange
Nasdaq
Location
US